PHARMACIE FREDERIC: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMACIE FREDERIC
Largest movements
- Receivables within one year -€48,105
down €48,105 (-29.7%), from €161,699 to €113,594
of which Trade receivables: -€47,074
- Cash +€22,213
up €22,213 (+58.9%), from €37,745 to €59,958
mainly Receivables within one year (+€48,105) and Depreciation (+€38,782)
- Advances received -€67,900
no longer reported in 2025 (was €67,900)
- Trade debts +€29,523
up €29,523 (+14.0%), from €210,354 to €239,877
- Debts after one year +€13,665
up €13,665 (+15.7%), from €87,182 to €100,847
of which Financial debts: +€16,665
- Other debts -€12,987
down €12,987 (-50.9%), from €25,518 to €12,531
- Profit (loss) carried forward +€11,195
up €11,195 (+30.4%), from €36,798 to €47,993
- Gross operating margin +€62,916
up €62,916 (+97.1%), from €64,808 to €127,724
- Staff costs +€10,787
up €10,787 (+33.3%), from €32,391 to €43,178
- Financial charges +€8,207
up €8,207 (+154%), from €5,326 to €13,533
- Taxes +€3,665
new in 2025: €3,665
- Depreciation +€3,607
up €3,607 (+10.3%), from €35,175 to €38,782
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €467,712 | €443,919 | -€23,793 | -5.1% |
| Fixed assets | 21/28 | €192,378 | €194,070 | +€1,692 | +0.9% |
| Tangible fixed assets | 22/27 | €191,878 | €193,570 | +€1,692 | +0.9% |
| Land and buildings | 22 | €60,079 | €54,603 | -€5,476 | -9.1% |
| Plant, machinery and equipment | 23 | €129,612 | €123,806 | -€5,806 | -4.5% |
| Furniture and vehicles | 24 | €2,187 | €15,161 | +€12,974 | +593% |
| Financial fixed assets | 28 | €500 | €500 | = | 0.0% |
| Current assets | 29/58 | €275,334 | €249,849 | -€25,485 | -9.3% |
| Stocks and contracts in progress | 3 | €73,222 | €74,401 | +€1,179 | +1.6% |
| Stocks | 30/36 | €73,222 | €74,401 | +€1,179 | +1.6% |
| Amounts receivable within one year | 40/41 | €161,699 | €113,594 | -€48,105 | -29.7% |
| Trade receivables | 40 | €159,971 | €112,897 | -€47,074 | -29.4% |
| Other amounts receivable | 41 | €1,728 | €697 | -€1,031 | -59.7% |
| Cash at bank and in hand | 54/58 | €37,745 | €59,958 | +€22,213 | +58.9% |
| Deferred charges and accrued income | 490/1 | €2,668 | €1,896 | -€772 | -28.9% |
| Total equity and liabilities | 10/49 | €467,712 | €443,919 | -€23,793 | -5.1% |
| Equity | 10/15 | €57,874 | €69,069 | +€11,195 | +19.3% |
| Contributions | 10/11 | €19,160 | €19,160 | = | 0.0% |
| Reserves | 13 | €1,916 | €1,916 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,916 | €1,916 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,916 | €1,916 | = | 0.0% |
| Profit (loss) carried forward | 14 | €36,798 | €47,993 | +€11,195 | +30.4% |
| Amounts payable | 17/49 | €409,838 | €374,850 | -€34,988 | -8.5% |
| Amounts payable after more than one year | 17 | €87,182 | €100,847 | +€13,665 | +15.7% |
| Financial debts | 170/4 | €81,182 | €97,847 | +€16,665 | +20.5% |
| Other amounts payable | 178/9 | €6,000 | €3,000 | -€3,000 | -50.0% |
| Amounts payable within one year | 42/48 | €322,141 | €273,515 | -€48,626 | -15.1% |
| Current portion of amounts payable after more than one year | 42 | €11,778 | €12,039 | +€261 | +2.2% |
| Trade debts | 44 | €210,354 | €239,877 | +€29,523 | +14.0% |
| Suppliers | 440/4 | €210,354 | €239,877 | +€29,523 | +14.0% |
| Advances received on contracts in progress | 46 | €67,900 | - | -€67,900 | |
| Taxes, remuneration and social security | 45 | €6,591 | €9,068 | +€2,477 | +37.6% |
| Taxes | 450/3 | - | €2,166 | +€2,166 | |
| Remuneration and social security | 454/9 | €6,591 | €6,902 | +€311 | +4.7% |
| Other amounts payable | 47/48 | €25,518 | €12,531 | -€12,987 | -50.9% |
| Accrued charges and deferred income | 492/3 | €515 | €488 | -€27 | -5.2% |
| Remuneration, social security and pensions | 62 | €32,391 | €43,178 | +€10,787 | +33.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €35,175 | €38,782 | +€3,607 | +10.3% |
| Other operating charges | 640/8 | €6,377 | €5,645 | -€732 | -11.5% |
| Gross operating margin | 9900 | €64,808 | €127,724 | +€62,916 | +97.1% |
| Operating profit (loss) | 9901 | -€9,135 | €40,119 | +€49,254 | |
| Financial income | 75/76B | - | €274 | +€274 | |
| Recurring financial income | 75 | - | €274 | +€274 | |
| Financial charges | 65/66B | €5,326 | €13,533 | +€8,207 | +154% |
| Recurring financial charges | 65 | €5,326 | €13,533 | +€8,207 | +154% |
| Profit (loss) for the period before taxes | 9903 | -€14,461 | €26,860 | +€41,321 | |
| Income taxes | 67/77 | - | €3,665 | +€3,665 | |
| Profit (loss) for the period | 9904 | -€14,461 | €23,195 | +€37,656 | |
| Profit (loss) for the period to be appropriated | 9905 | -€14,461 | €23,195 | +€37,656 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 24 October 2026 via checked.be.